BIO logo

  • June 16-19, 2025
  • Boston Convention & Exhibition Center

Sessions

Loading
Search Filters
  • Date
  • Focus Area
  • Start time
  • Session Type
We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
6:30 AM – 9:00 AM
(PST)
  1. KBI Biopharma 5K at BIO 2024
    Session
9:00 AM – 12:00 PM
(PST)
  1. Partnering with the U.S. Government to Achieve Our National Security Mission
    Breakout Session
    • Infectious Disease and Vaccines
    28ABCDE
9:05 AM – 9:40 AM
(PST)
  1. U.S. Engagement Day Opening Remarks
    DOD/BARDA
    • Infectious Disease and Vaccines
    Paul Friedrichs
    Paul Friedrichs, Maj. Gen. (ret), Deputy Assistant to the President - Director of the Office of Pandemic Preparedness and Response at the White House
    David Smith
    David Smith, Deputy Assistant Secretary of Defense for Health Readiness Policy and Oversight - Department of Defense (DOD)
    Dawn O'Connell
    Dawn O'Connell, Assistant Secretary for Preparedness and Response (ASPR), HHS - U.S. Department of Health and Human Services
9:45 AM – 10:40 AM
(PST)
  1. US and Global Partnerships to Achieve Better Global Preparedness and Response
    DOD/BARDA
    • Infectious Disease and Vaccines
    Jennifer Alton
    Jennifer Alton, President - Pathway Policy Group
    Chris Houchens
    Chris Houchens, Director Division CBRN MCMs - BARDA
    Emma Wheatley
    Emma Wheatley, Director, Access and Private Partnerships - CEPI
    Timothy Belski
    Timothy Belski, Branch Chief, Biopharmaceutical Manufacturing Preparedness (BioMaP) - BARDA
    Laurent Muschel
    Laurent Muschel, Acting Director General - European Commission, Health Emergency Preparedness and Response Authority (HERA)
    Brad Norwood
    Brad Norwood, Division Chief, Advanced and Emerging Threats, Joint Science and Technology Office - Defense Threat Reduction Agency
    Nicole Kilgore
    Nicole Kilgore, JPEO-CBRND - Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense/Joint Pro
10:00 AM – 11:00 AM
(PST)
  1. APAC: A Top Rate Destination for Complex and Challenging Clinical Trials
    Breakout Session
    • Asia-Pacific Opportunities
    30ABC
    novotech
    Judith Ng-Cashin
    Judith Ng-Cashin, Chief Medical Officer - Novotech
    Srini Ramanathan
    Srini Ramanathan, Chief Development Officer - Roivant
    Zach Gobst
    Zach Gobst, Founder and CEO - Leapcure
    Mark Tang
    Mark Tang, Managing Director - Good Health Capital
    Yao Li Ho
    Yao Li Ho, Managing Director - LYFE Capital
    Han Ying
    Han Ying, Chief Executive Officer - Gyre Therapeutics
10:45 AM – 11:30 AM
(PST)
  1. Aiming at a Moving Target: Enabling Technology to Adapt to Evolving Threats
    DOD/BARDA
    • Infectious Disease and Vaccines
    28ABCDE
    Taylor Sexton
    Taylor Sexton, Principal, Health Policy and Medical Countermeasures - Todd Strategy Group
    Arlene Joyner
    Arlene Joyner, Deputy Assistant Secretary Director, Office of Industrial Base Management and Supply Chain, ASPR - HHS
    David Kaslow
    David Kaslow, Director, Office of Vaccine Research and Review, CBER - FDA
    Wolfgang Philipp
    Wolfgang Philipp, Principal Advisor – Chief Science Officer - HERA
    Timothy Schiavoni
    Timothy Schiavoni, Director, Advanced Development and Manufacturing Capabilities (ADMC) - JPL-CBRND Enabling Biotechnologies
11:00 AM – 11:45 AM
(PST)
  1. Funding from a Japanese Investment Perspective
    Breakout Session
    • Asia-Pacific Opportunities
    30ABC
    Amy Nguyen
    Amy Nguyen, Vice President, Business Development and Relationship Management - Catalyst Clinical Research
    Takaaki Tobaru
    Takaaki Tobaru, Partner - Remiges Ventures
    Scott Kahn
    Scott Kahn, Chairman, ICAN Biomarkers Council; Founder - Alykomed Global Solutions LLC
    Ryusuke Sakamoto
    Ryusuke Sakamoto, General Manager, Business Development - Sanwa Kagaku Kenkyusho Co., Ltd.
11:30 AM – 1:00 PM
(PST)
  1. Premier & General Attendee Lunch
    Session Sails Pavilion
11:35 AM – 11:55 AM
(PST)
  1. Unlocking the Door to Government Partnerships
    DOD/BARDA
    • Infectious Disease and Vaccines
    Jeremiah Kelly
    Jeremiah Kelly, Partner - Venable LLP
    Gary Disbrow
    Gary Disbrow, Deputy Assistant Secretary Director - BARDA
    Matt Clark
    Matt Clark, Chemical, Biological, Radiological and Nuclear (CBRN) Medical Joint Project Manager - JPEO-CBRND
    Jennifer Kruk
    Jennifer Kruk, Program Manager, Joint Science and Technology Office (JSTO)/Research and Development, Chem/Bio Technologies - Defense Threat Reduction Agency
12:00 PM – 1:00 PM
(PST)
  1. How to Build a Successful and Competitive Biopharma Ecosystem in Southeast Asia
    Breakout Session
    • Asia-Pacific Opportunities
    30ABC
    Mai Zymaris
    Mai Zymaris, Counsel - Baker McKenzie
    Phong Tran
    Phong Tran, CEO - BOUND Therapeutics and siRnaMed Therapeutics
    John Mattison
    John Mattison, Operating Partner and Chief Medical Information Officer - Arsenal Capital Partners
    Anh Hoang-Lindsay
    Anh Hoang-Lindsay, CEO - Jana Care
    Alex Wang
    Alex Wang, Head of Business Development, US & China - Zuellig Pharma
12:15 PM – 6:00 PM
(PST)
  1. Company Presentations Monday
    Company Presentation Session Company Presentation Theaters
    johnson and johnson
12:30 PM – 1:30 PM
(PST)
  1. Focal Biosciences
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 3
    Glenn Croston
    Glenn Croston, Chief Operations Officer - Focal Biosciences
  2. Hua Medicine
    Company Presentation
    • Metabolic Diseases
    Company Presentation Theater 2
    George Lin
    George Lin, EVP & Chief Strategy Officer - Hua Medicine
  3. Pepper Bio
    Company Presentation
    • Oncology
    Company Presentation Theater 4
    Samantha Dale Strasser
    Samantha Dale Strasser, CSO and Cofounder - Pepper Bio
  4. ReCode Therapeutics
    Company Presentation
    • Other
    Company Presentation Theater 1
    Ariel Kantor
    Ariel Kantor, Head of Business and Corporate Development - ReCode Therapeutics
  5. Sustainable Talent Development for Biomanufacturing of the Future
    BioProcess Theater BioProcess Theater
    Sue Behrens
    Sue Behrens
    Keau Wong
    Keau Wong
    Gargi Ghosh
    Gargi Ghosh, Associate Professor - Keck Graduate Institute
    John Belchunas
    John Belchunas
    Mike Alston
    Mike Alston, Vice President, Operations - Avid Bioservices
12:45 PM – 1:00 PM
(PST)
  1. Avidicure B.V.
    Company Presentation
    • Oncology
    Company Presentation Theater 4
    Robert Friesen
    Robert Friesen, Chief Scientific Officer - Avidicure B.V.
  2. Extend Biosciences
    Company Presentation
    • Metabolic Diseases
    Company Presentation Theater 2
    Tarik Soliman
    Tarik Soliman, CEO and President - Extend Biosciences
  3. GenEdit
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 3
    Barbara Leyman
    Barbara Leyman, SVP, Corporate Development - GenEdit
  4. VerImmune Inc
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Joshua Wang
    Joshua Wang, Founder & CEO - VerImmune Inc
1:00 PM – 1:15 PM
(PST)
  1. APAC Summit Networking Lunch
    Breakout Session
    • Asia-Pacific Opportunities
    30ABC
  2. Future Medicine
    Company Presentation
    • Metabolic Diseases
    Company Presentation Theater 2
    Jangyoun Hwang
    Jangyoun Hwang, Director - Future Medicine
  3. Neopharmed Gentili S.p.A.
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 3
    Eric Falcand
    Eric Falcand, CEO - Neopharmed Gentili S.p.A.
  4. Rady Children's Institute for Genomic Medicine
    Company Presentation
    • Orphan and Rare Disease
    Company Presentation Theater 1
    Stephen Kingsmore
    Stephen Kingsmore, President & CEO - Rady Children's Institute for Genomic Medicine
  5. VelaVigo
    Company Presentation
    • Oncology
    Company Presentation Theater 4
    Tong Zhang
    Tong Zhang, Co Founder, CBO/CFO - VelaVigo
1:15 PM – 1:30 PM
(PST)
  1. Accession Therapeutics Limited
    Company Presentation
    • Oncology
    Company Presentation Theater 4
    Stephanie Bewick
    Stephanie Bewick, Chief Business Officer - Accession Therapuetics
  2. AustarPharma,LLC
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 2
    Ron Liu
    Ron Liu, CEO - AustarPharma, LLC
  3. Shanghai Synergy Pharmaceutical Sciences Co., Ltd., A wholly owned subsidiary of Huahai Pharmaceutical Co., Ltd.
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 3
    Min Li
    Min Li, Board Chair - Shanghai Synergy Pharmaceutical Sciences Co., Ltd.
  4. ZTI BIOSCIENCES
    Company Presentation
    • Other
    Company Presentation Theater 1
    Jaden Hyungseok Chang
    Jaden Hyungseok Chang, CEO - ZTI Biosciences
1:30 PM – 1:45 PM
(PST)
  1. Bilayer Therapeutics, Inc.
    Company Presentation
    • Metabolic Diseases
    Company Presentation Theater 2
    Thomas Collet
    Thomas Collet, President & CEO, Co-Founder - Bilayer Therapeutics, Inc.
  2. Esphera SynBio Inc
    Company Presentation
    • Oncology
    Company Presentation Theater 4
    Brian Lichty
    Brian Lichty, CEO - Esphera SynBio Inc
  3. Hexagon Bio
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Maureen Hillenmeyer
    Maureen Hillenmeyer, CEO - Hexagon Bio
  4. Humanetics Corporation
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 3
    Ronald Zenk
    Ronald Zenk, Chief Executive Officer - Humanetics Corporation
1:45 PM – 2:45 PM
(PST)
  1. A Discussion on Increasing Healthspan
    Breakout Session
    • Next Generation Biotherapeutics
    23BC
    Hilary Brueck
    Hilary Brueck, Journalist - Business Insider
    Dan Oliver
    Dan Oliver, CEO & Co-Founder - Rejuvenate Bio
    Katharine Grabek
    Katharine Grabek, Co-Founder and CSO - Fauna Bio
    Jake Becraft
    Jake Becraft, CEO & Founder - Strand Therapeutics
    Alex Aravanis
    Alex Aravanis, CEO - Moonwalk Biosciences
    Jennifer Bergheiser
    Jennifer Bergheiser, Chief Business Officer - eGenesis
  2. A Licensing Deal for All Seasons
    Breakout Session
    • Business Development and Finance
    29AB
    Jonathan Grinstein
    Jonathan Grinstein, Senior Editor - Inside Precision Medicine
    Uneek Mehra
    Uneek Mehra, CHIEF FINANCIAL & BUSINESS OFFICER - 4DMT
    Kunal Patel
    Kunal Patel, VP of Business Development - Synthekine
    Gavin Samuels
    Gavin Samuels, Chief Business Officer - CinRx Pharma
    Lesley Stolz
    Lesley Stolz, Vice President - Johnson & Johnson Innovation
    Richard Wilson
    Richard Wilson, Senior VP, Primary Focus Lead of Genetic Regulation - Astellas Gene Therapies
  3. All Money is NOT Created Equal: The Differences between Angel, Venture and Strategic Capital in the Biotech Funding Ecosystem
    Breakout Session
    • Business Development and Finance
    32AB
    Yaniv Sneor
    Yaniv Sneor, Founder & Managing Director - Mid Atlantic Bio Angels
    Jonathan McClain
    Jonathan McClain, Executive Director, Eli Lilly Catalyze team - Eli Lilly
    Max Farina
    Max Farina, Senior Associate - 5AM Ventures
    Alexey Konov
    Alexey Konov, Managing Partner - Biovision Ventures
  4. Alternative Funding Programs: Protecting Patients in an Ever-Changing Healthcare Landscape
    Breakout Session
    • Patient Advocacy
    26A
    Ashira Vantrees
    Ashira Vantrees, Counsel - Aimed Alliance
    Kollet Koulianos
    Kollet Koulianos, Senior Payer Advisor - Hemophilia Alliance
    Kim Czubaruk
    Kim Czubaruk, Associate Vice President of Policy - Cancer Care
    Richard Meyers
    Richard Meyers, Head, State Policy - Bristol Myers Squibb
    Theresa Alban
    Theresa Alban, Senior Manager, Federal Policy - Cystic Fibrosis Foundation
  5. Aurion Biotech
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    Greg Kunst
    Greg Kunst, CEO - Aurion Biotech
  6. Bristol Myers Squibb
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 2
    Lauren Cautilli
    Lauren Cautilli, Manager, SBD External Event Operations - Bristol Myers Squibb
  7. Building Capacities in the Industry for Secondary Uses of Health Data: The EHDS Framework
    Breakout Session
    • AI and Digital Health
    24BC
    Montse Daban
    Montse Daban, Director of Strategic Foresight at Biocat; President - CEBR
    Jean Marc Bourez
    Jean Marc Bourez, CEO - EIT Heatlth
    Elina Drakvik
    Elina Drakvik, Senior lead, Health Data 2030 - Sitra
    Aenor Sawyer
    Aenor Sawyer, Director UC Space Health - University of San Francisco
    Brad Ship
    Brad Ship, Partner - Alira Health
    Chris Morton
    Chris Morton, Business Executive and CEO - ELEM Biotech
  8. Empowering Real World Patient-Centric Digital Health in Asia with Digital Apps
    Breakout Session
    • Asia-Pacific Opportunities
    30ABC
    Peter Kurz
    Peter Kurz, Chief Strategy Officer - QIC International
    Yen-Yin Lin
    Yen-Yin Lin, Co-founder & CEO - JelloX Biotech Inc.
    Jarret Chia-Ju Su
    Jarret Chia-Ju Su, Co-Head of Healthcare & Life Science - KPMG in Taiwan
    Edward Deng
    Edward Deng, co-founder and CEO - Health2Sync
    Amy Hsiao
    Amy Hsiao, Head of Product Management - Acer Medical
    Steven Lester
    Steven Lester, Cardiologist and Professor in Medicine - Mayo Clinic
  9. Europe's Policy Environment and the Impact on the Biotech Sector
    Breakout Session
    • Emerging Opportunities in Global Markets
    26B
    Justin Pine
    Justin Pine, Senior Director - Biotechnology Innovation Organization (BIO)
    Matias Olsen
    Matias Olsen, Public Affairs & Policy Manager - EUCOPE
    Claire Skentelbery
    Claire Skentelbery, Director General - EuropaBio
    Santoke Naal
    Santoke Naal, Managing Director - IGES UK
    Steffen Thirstrup
    Steffen Thirstrup, Chief Medical Officer - European Medicines Agency (EMA)
    Thomas Bols
    Thomas Bols, Head of Government Affairs and Patient Engagement, EMEA & APAC - PTC Therapeutics
  10. Super Session
    Fireside Chat with Nauman Shah, Global Head of Business Development, Johnson & Johnson Innovative Medicine
    Super Session
    • Business Development and Finance
    28ABCDE
    johnson and johnson
    Michelle Davis
    Michelle Davis, M&A Reporter - Bloomberg News
    Nauman Shah
    Nauman Shah, Global Head of Business Development - Johnson & Johnson Innovative Medicine
  11. Glykos Finland Oy
    Company Presentation
    • Oncology
    Company Presentation Theater 4
    Juhani Saarinen
    Juhani Saarinen, CEO - Glykos Finland Oy
  12. Lessons from the Oregon Trail: Pioneering Gene Therapy in the Real World
    Breakout Session
    • Cell and Gene Therapy and Genome Editing
    31AB
    Tom Klima
    Tom Klima, Chief Operating and Commercial Officer - bluebird bio
    Joe Garrity
    Joe Garrity, Senior Director, Head of Cell and Gene Therapy Customer Proposals - Lonza
    Tim Olson
    Tim Olson, Medical Director, Blood and Marrow Transplant Program - Children's Hospital of Philadelphia
    Michelle Campbell
    Michelle Campbell, Caregiver - N/A
    Kirk Davis
    Kirk Davis, Cigna Healthcare Gene Therapy Program, Senior Manager - Cigna
  13. Tharimmune, Inc.
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 3
    Sireesh Appajosyula
    Sireesh Appajosyula, Chief Operating Officer - Tharimmune, Inc.
  14. The Cross-Border Applicability of RWD in Decision-Making
    Breakout Session
    • Regulatory Innovation
    31C
    Rachel Ehlers
    Rachel Ehlers, Partner - Baker McKenzie
    Michele Colucci
    Michele Colucci, Founder & Managing Partner - DigitalDx Ventures
    Michelle Wong
    Michelle Wong, Head of Operations - Octant
    Jonathan Fairtlough
    Jonathan Fairtlough, Principal, Advisory, Cyber Security Services - KPMG US
    Virginia Sanzone
    Virginia Sanzone, General Counsel - ICU Medical
  15. The Time is Now: Global Perspectives on Preparing for Public Health Emergencies
    Breakout Session
    • Infectious Disease and Vaccines
    29C
    Emergent logo
    Chris Frech
    Chris Frech, Senior Vice President Global Government Affairs - Emergent BioSolutions
    Brett Sutton
    Brett Sutton, Director, Health & Biosecurity - CSIRO
    Wolfgang Philipp
    Wolfgang Philipp, Principal Advisor – Chief Science Officer - HERA
    Oliver Schacht
    Oliver Schacht, Executive VP Corporate Development - OpGen
    Ambika Bumb
    Ambika Bumb, Deputy Executive Director - Bipartisan Commission on Biodefense
2:00 PM – 2:15 PM
(PST)
  1. Bridge Biotherapeutics
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 3
    Pavel Printsev
    Pavel Printsev, Director, Business Development - Bridge Biotherapeutics
  2. Digital Transformation for Start-up and Mid-sized Life Science manufacturing sites
    BioProcess Theater BioProcess Theater
    John Clapham
    John Clapham
  3. Genprex, Inc.
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    Ryan Confer
    Ryan Confer, Chief Financial Officer - Genprex, Inc.
  4. Novo Nordisk
    Company Presentation
    • Metabolic Diseases
    Company Presentation Theater 2
    Tari Suprapto
    Tari Suprapto, Director, Search & Evaluation (Western US & Canada) - Novo Nordisk
  5. StemSynergy Therapeutics
    Company Presentation
    • Oncology
    Company Presentation Theater 4
    Dennis Fei
    Dennis Fei, Director of Drug Discovery and Development - StemSynergy Therapeutics
2:15 PM – 2:30 PM
(PST)
  1. Amgen Inc.
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 2
    Omari Wise
    Omari Wise, Vice President Business Development - Amgen
  2. Cellphire Therapeutics, Inc
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 3
    Mike Gaffney
    Mike Gaffney, CEO - Cellphire Therapeutics, Inc
  3. Lisata Therapeutics
    Company Presentation
    • Oncology
    Company Presentation Theater 4
    David Mazzo
    David Mazzo, President and Chief Executive Officer - Lisata Therapeutics
  4. Ocugen, Inc.
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    Shankar Musunuri
    Shankar Musunuri, Chairman, CEO and Co-Founder - Ocugen, Inc.
2:30 PM – 2:45 PM
(PST)
  1. Maryland Tech Council- BioHub Maryland
    Company Presentation Company Presentation Theater 2
  2. Medosome Biotec, LLC
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 3
    Richard Wagner
    Richard Wagner, President - Medosome Biotec, LLC
  3. Osmol Therapeutics, Inc.
    Company Presentation
    • Oncology
    Company Presentation Theater 4
    Bob Linke
    Bob Linke, President & CEO - Osmol Therapeutics, Inc.
  4. Protalix Biotherapeutics
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    Dror Bashan
    Dror Bashan, President, CEO - Protalix Biotherapeutics
2:45 PM – 3:00 PM
(PST)
  1. Evaxion Biotech
    Company Presentation
    • Immunology
    Company Presentation Theater 2
    Christian Kanstrup
    Christian Kanstrup, CEO - Evaxion Biotech
  2. Orizuru Therapeutics, Inc.
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    Shinji Ogawa
    Shinji Ogawa, Vice president and Chief Operating Officer - Orizuru Therapeutics, Inc.
  3. PDX Pharmaceuticals
    Company Presentation
    • Oncology
    Company Presentation Theater 4
    Worapol Ngamcherdtrakul
    Worapol Ngamcherdtrakul, COO - PDX Pharmaceuticals
  4. Vivacelle Bio,Inc.
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 3
    Cuthbert Simpkins
    Cuthbert Simpkins, President/Chief Innovation Officer - Vivacelle Bio, Inc
3:00 PM – 3:15 PM
(PST)
  1. A New Era for Access and Affordability: Considerations for Patients and Manufacturers in a Post-IRA World
    Breakout Session
    • Patient Advocacy
    26A
    Mark Gooding
    Mark Gooding, Managing Director - Avalere
    Anna Hyde
    Anna Hyde, Vice President of Advocacy and Access - Arthritis Foundation
    Valerie Reynolds
    Valerie Reynolds, Executive Director - Genentech
    Eric Gascho
    Eric Gascho, Senior Vice President, Policy and Government Affairs - National Health Council
  2. A Perspective from the Trenches: Challenges of Budgeting for Gene Therapies, Innovative Payment Systems That Work for Medicaid Departments and Patients, and What the States Need from CMS
    Breakout Session
    • Cell and Gene Therapy and Genome Editing
    31AB
    Thomas Barker
    Thomas Barker, Partner - Foley Hoag LLP
    Scott McGoohan
    Scott McGoohan, Executive Director, Policy and Alliance Development - Vertex Pharmaceuticals
    Jay Newman
    Jay Newman, SVP, Commercial Development, Pricing & Reimbursement - Spark Therapeutics, Inc.
    Stuart Portman
    Stuart Portman, Executive Director, Division of Medical Assistance Plans - State of Georgia
    James Uli
    James Uli, Senior Vice President and Chief Financial Officer - Rady Children's Hospital and Health Center
  3. Accuredit Therapeutics US limited
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    Yongzhong Wang
    Yongzhong Wang, CEO - Accuredit Therapeutics US Limited
  4. AI and Regulatory Innovation in Healthcare: Shaping the Future
    Breakout Session
    • Regulatory Innovation
    31C
    Paul Howard
    Paul Howard, Senior Director, Public Policy - Amicus Therapeutics
    Meredith Brown-Tuttle
    Meredith Brown-Tuttle, Chief Regulatory Strategist - Regulatorium
    Brandon Rice
    Brandon Rice, Chief Product Officer - Weave Bio
    Mida Pezeshkian
    Mida Pezeshkian, Founder, Principle - STEMA_cg
    Christopher Hart
    Christopher Hart, Partner - Foley Hoag
  5. An Insider Look at Top Deals from 2023
    Breakout Session
    • Business Development and Finance
    29AB
    Carin Canale-Theakston
    Carin Canale-Theakston, Executive Biotech Advisor - Inizio
    Mark McKenna
    Mark McKenna, CEO - Mirador Therapeutics
    Enoch Kariuki
    Enoch Kariuki, President - Endeavor Biomedicines
    Ken Song
    Ken Song, former CEO - RayzeBio
    Remy Durand
    Remy Durand - Vertex
  6. Asahi Kasei Pharma corporation
    Company Presentation
    • Immunology
    Company Presentation Theater 2
    Takeshi Ohno
    Takeshi Ohno, Executive Officer - Asahi Kasei Pharma Corporation
  7. Biotech Beyond Borders: Emerging Stronger from a Complex Macroenvironment
    Breakout Session
    • Business Development and Finance
    32AB
    Arda Ural
    Arda Ural, Americas Life Sciences Sector Leader - EY (Ernst & Young)
    Chris Garabedian
    Chris Garabedian, VC Portfolio Manager - Perceptive Advisors
    Barbara Ryan
    Barbara Ryan, Board Member, Senior Advisor to EY, Indivior, Mink, Invo, SafeCor Pharmaceutical Companies
    Brian Bronk
    Brian Bronk, Head of Business Development, Neurology, Rare Diseases, Technology Platforms and R&D Transactions Partnering - Sanofi
    Julie Rozenblyum
    Julie Rozenblyum, Senior Vice President, Business Development - BMS
  8. Capabilities for Advanced Biomanufacturing: Enhancing opportunities and meeting challenges for global access
    BioProcess Theater BioProcess Theater
    Rob Welsh
    Rob Welsh, VP-Biopharma Production Solutions - Avantor
    Ilya Goldberg
    Ilya Goldberg, Chief Science Officer - ViQi
    Craig Vincze
    Craig Vincze, Vice President and Co-founder - Alphinity
    Flaka Radoniqi
    Flaka Radoniqi, Principal Scientist, Pivotal Biologics Drug Substance Technologies - Amgen
  9. Emerging Technologies Fostering Biotech Innovation Globally
    Breakout Session
    • Emerging Opportunities in Global Markets
    26B
    Falk Ehmann
    Falk Ehmann, Head of Innovation and Development Accelerator (IDeA) - European Medicines Agency (EMA)
    Blythe Adamson
    Blythe Adamson, Senior Principal Scientist, Head of Outcomes Research - Flatiron Health
    Carmen Laplaza-Santos
    Carmen Laplaza-Santos, Head of Unit Health Innovations and Ecosystems in Directorate General on Research and Innovation - European Commission
    Robert Schröder
    Robert Schröder, Head of Sector External Communication (EISMEA) - European Innovation Council
    Mahesh Yadav
    Mahesh Yadav, Distinguished Scientist - Genentech
    Ferenc Marofka
    Ferenc Marofka - European Commission
  10. Fireside Chat
    Fireside Chat with Nina Kjellson, General Partner, Canaan Partners
    Fireside Chat
    • Business Development and Finance
    30DE
    Allison DeAngelis
    Allison DeAngelis, Reporter - STAT News
    Nina Kjellson
    Nina Kjellson, General Partner - Canaan Partners
  11. Fireside Chat
    Fireside Chat with Stephen Quake, Head of Science, Chan Zuckerberg Initiative
    Fireside Chat
    • Next Generation Biotherapeutics
    25ABC
    Jonathan Wosen
    Jonathan Wosen, West Coast Biotech & Life Sciences Reporter - STAT
    Steve Quake
    Steve Quake, Head of Science - Chan Zuckerberg Initiative
  12. Forging New Pathways to Reimbursement for Digital Therapeutics: Considerations for Payer Coverage
    Breakout Session
    • AI and Digital Health
    24BC
    Brigit Kyei-Baffour
    Brigit Kyei-Baffour, Principal - Avalere
    Jon Campbell
    Jon Campbell, Chief Science Officer - National Pharmaceutical Council
    Dirk Soenksen
    Dirk Soenksen, Co-founder and CEO - Ceresti Health
    Beth Rogozinski
    Beth Rogozinski, CEO - Oncoustics
    Chris Koch
    Chris Koch, CEO - LeGen Medicial Devices
  13. Global Policy Perspectives on the Next Generation of Rare Disease Medicines
    Breakout Session
    • Orphan and Rare Disease
    28ABCDE

    merck logo

    Jannie Oosthuizen
    Jannie Oosthuizen, President, Merck Human Health U.S. - Merck
    Karin Hoelzer
    Karin Hoelzer, Senior Director, Policy and Regulatory Affairs - National Organization for Rare Disorders (NORD)
    Durhane Wong-Rieger
    Durhane Wong-Rieger, President & CEO - Canadian Organization for Rare Disorders (CORD)
    Ryan MacFarlane
    Ryan MacFarlane, Vice President - Access Partnership
    His Excellency Mansoor Al Mansoori
    His Excellency Mansoor Al Mansoori, Abu Dhabi Executive Council Member and Chairman of the Department of Health - Abu Dhabi
  14. Let’s Go STEDI: Moving Beyond QALY’s to Understand the True Value of Antimicrobials and Vaccines
    Breakout Session
    • Infectious Disease and Vaccines
    29C
    Ted Buckley
    Ted Buckley, Vice President, Government Affairs - Shionogi
    John Rex
    John Rex, Chief Medical Officer - F2G
    Scott Johnson
    Scott Johnson, CEO/Founder - Medicus Economics
    Ella Balasa
    Ella Balasa, Patient Expert - Balasa Consulting
  15. Longevity Therapeutics Enter Biopharma Mainstream
    Breakout Session
    • Next Generation Biotherapeutics
    23BC
    Brian Gormley
    Brian Gormley, Reporter - Wall Street Journal
    Marco Quarta
    Marco Quarta, Founder and CEO - Rubedo Life Sciences
    Robert Gould
    Robert Gould, Operating Partner - Khosla Ventures
    Simone Fantaccini
    Simone Fantaccini, Chief Scientific Officer & Head of Medical Affairs - Novartis
    Cristina Ghenoiu
    Cristina Ghenoiu, Investor - Mubadala Capital
    Hanadie Yousef
    Hanadie Yousef, Chief Executive Officer and Co-Founder - Juvena Therapeutics
  16. Patients Wait Less: Streamlining Regulatory Pathways for Cell/Gene Therapies in Asia-Pacific Region
    Breakout Session
    • Asia-Pacific Opportunities
    30ABC
    Wallace Lin
    Wallace Lin, Secretary-General - Taiwan BIO
    Yueh-Ping Liu
    Yueh-Ping Liu, Director-General, Department of Medical Affairs - Ministry of Health and Welfare of Taiwan
    Chia-Hua (Maggie) Ho
    Chia-Hua (Maggie) Ho, Chief Operating Officer - Amarex Taiwan, LLC
    Joseph Damond
    Joseph Damond, Chair, Global Life Sciences - Crowell & Moring International LLC
    Yoshiaki Maruyama
    Yoshiaki Maruyama, Review Director at the Office of Cellular and Tissue-based Products - PMDA
  17. Triastek, Inc.
    Company Presentation
    • Other
    Company Presentation Theater 4
    Yulian Zhang
    Yulian Zhang, VP of Global BD - Triastek, Inc.
  18. Vasomune Therapeutics Inc
    Company Presentation
    • Respiratory
    Company Presentation Theater 3
    BRIAN JAHNS
    BRIAN JAHNS, President & Chief Operating Officer - Vasomune Therapeutics inc
3:15 PM – 3:30 PM
(PST)
  1. Artax Biopharma
    Company Presentation
    • Immunology
    Company Presentation Theater 2
    Christopher VanDeusen
    Christopher VanDeusen, Chief Scientific Officer - Artax Biopharma
  2. Inhalon Biopharma, Inc.
    Company Presentation
    • Respiratory
    Company Presentation Theater 3
    John Whelan
    John Whelan, President, CEO - Inhalon, Biopharma, Inc.
  3. Moonwalk Biosciences, Inc.
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    Alex Aravanis
    Alex Aravanis, CEO - Moonwalk Biosciences
  4. Rejuvenate Biomed
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    Ann Belien
    Ann Belien, Founder & CEO - Rejuvenate Biomed
3:30 PM – 3:45 PM
(PST)
  1. Avistone Biotechnology
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    David Chung
    David Chung, Chief Business Officer - Avistone Biotechnology
  2. Ceria Therapeutics, Inc.
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    David Jackson
    David Jackson, CEO - Ceria Therapeutics, Inc.
  3. Doloromics
    Company Presentation
    • Pain Management
    Company Presentation Theater 3
    Jackson Brougher
    Jackson Brougher, Chief Science Officer - Doloromics
  4. PlantPharm Biomed, Ltd
    Company Presentation
    • Infectious Disease and Vaccines
    Company Presentation Theater 2
    Richard Matner
    Richard Matner, President and Chief Strategy Officer - PlantPharm Biomed, Ltd
3:45 PM – 4:00 PM
(PST)
  1. Avery Therapeutics, Inc.
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    Jordan Lancaster
    Jordan Lancaster, Chief Executive Officer - Avery Therapeutics, Inc.
  2. BTB Therapeutics
    Company Presentation
    • Pain Management
    Company Presentation Theater 3
    Takashi Kiyoizumi
    Takashi Kiyoizumi, CFO - BTB Therapeutics
  3. GeoVax Labs, Inc.
    Company Presentation
    • Immunology
    Company Presentation Theater 2
    David Dodd
    David Dodd, Chairman & CEO - GeoVax Labs, Inc.
  4. Predictive Oncology
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Raymond Vennare
    Raymond Vennare, Chief Executive Officer - Predictive Oncology
4:00 PM – 4:15 PM
(PST)
  1. Investissement Québec International
    Global Innovation Hub 5A
    Georges Ged
    Georges Ged, Senior Director Foreign Direct Investment - Life Sciences & Health Technologies - Investissement Québec International
  2. Likarda, Inc
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    Stella Vnook
    Stella Vnook, CEO - Likarda
  3. Shanghai Novamab Biopharmaceuticals Co., Ltd.
    Company Presentation
    • Immunology
    Company Presentation Theater 2
    Yakun Wan
    Yakun Wan, CEO - Shanghai Novamab Biopharmaceuticals Co., Ltd.
  4. Virpax Pharmaceuticals, Inc.
    Company Presentation
    • Pain Management
    Company Presentation Theater 3
    Gerald Bruce
    Gerald Bruce, Chief Executive Officer - Virpax Pharmaceuticals Inc.
  5. VSPharmTech
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    HO YUN NAM
    HO YUN NAM, General Manager - VSPharmTech
4:15 PM – 5:15 PM
(PST)
  1. Agile Biologics Development and Manufacturing Strategies to Meet Market Demand
    Breakout Session
    • Business Development and Finance
    30DE
    thermofisher scientific
    Paul Jorjorian
    Paul Jorjorian, Vice President & General Manager, Biologics, Pharma Services - Thermo Fisher Scientific
    Glen Campbell
    Glen Campbell, Vice President, Head of External Operations - Vir Biotechnology
    Michael Deperro
    Michael Deperro, SVP, Corporate Development - Rezolute Inc
    Adam Pfeiffer
    Adam Pfeiffer, Vice President - Farma Project
  2. Altering the Regulatory Ecosystem for Pediatric Clinical Programs: Intended and Unintended Consequences
    Breakout Session
    • Regulatory Innovation
    31C
    Catherine Lee
    Catherine Lee, Associate Director, Global Regulatory Policy and Intelligence - Johnson & Johnson
    Laurie Conklin
    Laurie Conklin, Senior Director, Pediatric Development - Johnson & Johnson
    Dionna Green
    Dionna Green, Director, Office of Pediatric Therapeutics - FDA
    Thomas Miller
    Thomas Miller, Global Head, Acute, Chronic & Pediatric Disease Nucleus - Bayer
  3. Avoid the Cycle of “Panic and Neglect": How Ongoing Commitment to Innovative Partnerships Futureproofs Against the Next Pandemic
    Breakout Session
    • Infectious Disease and Vaccines
    29C
    Paul Friedrichs
    Paul Friedrichs, Maj. Gen. (ret), Deputy Assistant to the President - Director of the Office of Pandemic Preparedness and Response at the White House
    Georges Benjamin
    Georges Benjamin, Executive Director - American Public Health Association
    Laurent Muschel
    Laurent Muschel, Acting Director General - European Commission, Health Emergency Preparedness and Response Authority (HERA)
    Emma Wheatley
    Emma Wheatley, Director, Access and Private Partnerships - CEPI
    Dawn O'Connell
    Dawn O'Connell, Assistant Secretary for Preparedness and Response (ASPR), HHS - U.S. Department of Health and Human Services
    Kelly Cappio
    Kelly Cappio, Vice President, Global Policy and Government Affairs - Novavax
  4. Creative Structures for Keeping Innovation Alive After the Deal
    Breakout Session
    • Business Development and Finance
    29AB
    Oren Livne
    Oren Livne, Partner - Baker McKenzie
    Gavin Liu
    Gavin Liu, Senior Director, Legal Strategic Transactions - Astellas
    Deepa Talpade
    Deepa Talpade, Vice President, Head BD&L and Alliance Mgmt., Oncology - Bayer
    Maria Nichol
    Maria Nichol, Chief Business Officer - Artax Biopharma
    Ellen Lubman
    Ellen Lubman, Chief Business Officer - Werewolf Therapeutics
    Casarine Chong
    Casarine Chong, Senior Vice President, Deputy General Counsel, Transactions - Bristol Myers Squibb
  5. Epion Therapeutics
    Company Presentation
    • Ophthalmology
    Company Presentation Theater 3
    Michael Webb
    Michael Webb, CEO - Epion Therapeutics, Inc.
  6. Fireside Chat
    Fireside Chat with Matt Gline, CEO, Roivant Sciences
    Fireside Chat
    • Business Development and Finance
    25ABC
    Michelle Davis
    Michelle Davis, M&A Reporter - Bloomberg News
    Matt Gline
    Matt Gline, Chief Executive Officer - Roivant Sciences
  7. From Patients to Partners: Patient Advocacy and Biotech Collaborate to Accelerate Innovation
    Breakout Session
    • Patient Advocacy
    26A
    Anthony Mancini
    Anthony Mancini, EVP & Chief Operating Officer - Genmab
    Meghan Gutierrez
    Meghan Gutierrez, CEO - Lymphoma Research Foundation
    Portia Badham
    Portia Badham, Patient Advocate and Marketing/Communications Consultant
    Sabine Haubenreisser
    Sabine Haubenreisser, Principal Scientific Administrator, Stakeholders and Communications Division - European Medicines Agency (EMA)
  8. Gun Violence Prevention: A Case Study in Passing Meaningful Policies in a Hyper Partisan Era
    Special Program
    • Regulatory Innovation
    28ABCDE
    Josh Horwitz
    Josh Horwitz, Co-director - Johns Hopkins Center for Gun Violence Solutions
    Angus McQuilken
    Angus McQuilken, co-founder - Life Sciences to End Gun Violence Epidemic
    Jen Pauliukonis
    Jen Pauliukonis, Director of Policy and Programming - Johns Hopkins Center for Gun Violence Solutions
    Traci Murphy
    Traci Murphy, Executive Director - Delaware Coalition Against Gun Violence and Coalition For A Safer Delaware
  9. Innovation Passport: Emerging Opportunities for Company Growth in Global Markets
    Breakout Session
    • Business Development and Finance
    32AB
    Susie Harborth
    Susie Harborth, Chief Business Officer - Breakthrough Properties
    Bernard Parker
    Bernard Parker, Chief Business Officer - Shanghai Pharma Biotherapeutics USA, Inc.
    Avi Spier
    Avi Spier, Executive Director Business Development and Licensing - Novartis
    Kristen Albright
    Kristen Albright, CEO - Prokarium
    Wen Qi Ho
    Wen Qi Ho, Therapeutics Lead - ClavystBio
  10. Investors' Perspectives: Digital Health Trends and Investment Thesis in 2024 and Beyond
    Breakout Session
    • AI and Digital Health
    24BC
    Josh Seidenfeld
    Josh Seidenfeld, Partner and Chair, Digital Health - Cooley LLP
    Sourav Kole
    Sourav Kole, Managing Director - Dolby Family Ventures
    Mara Aspinall
    Mara Aspinall, Partner - Illumina Ventures
    Christina DelloRusso
    Christina DelloRusso, Partner - LRVHealth
    Matt Blum
    Matt Blum, Principal - Cigna Ventures
  11. Quality Standards for Final Preparation of CGT Product at Point of Care (POC)
    Breakout Session
    • Cell and Gene Therapy and Genome Editing
    31AB
    Maria Amaya
    Maria Amaya, Lead External Advocacy, Quality Policy and Advocacy - Genentech, A member of the Roche Group
    Lesbeth Rodriguez
    Lesbeth Rodriguez, Director, Regulatory Affairs, Policy and Innovation - Bayer
    Maria Sørensen
    Maria Sørensen, Specialist, RA CMC Lead - Novo Nordisk
    Steffen Thirstrup
    Steffen Thirstrup, Chief Medical Officer - European Medicines Agency (EMA)
    Heather Lombardi
    Heather Lombardi, Director, Office of Cellular Therapy and Human Tissue - FDA
  12. Recce Pharmaceuticals
    Company Presentation
    • Infectious Disease and Vaccines
    Company Presentation Theater 2
    James Graham
    James Graham, CEO - Recce Pharmaceuticals
  13. Reveal Pharma
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Srini Mukundan
    Srini Mukundan, Medical Director - Reveal Pharmaceuticals Inc
  14. Unlocking Biotech Growth: Hong Kong as the Gateway to Global Markets
    Breakout Session
    • Asia-Pacific Opportunities
    30ABC
    hkstp
    Albert Wong
    Albert Wong, CEO - Hong Kong Science and Technology Parks Corporation
    Grace Lau
    Grace Lau, Head, Institute for Translational Research - Hong Kong Science and Technology Parks Corporation
    Andy Wong
    Andy Wong, Head of Innovation and Technology - Invest Hong Kong
    Michael Chen
    Michael Chen, CEO & Co-founder - Great Bay Bio Limited
    Gaobo Zhou
    Gaobo Zhou, Chief Investment Officer - Simcere Pharmaceutical Group Limited
    Vicky Qu
    Vicky Qu, Senior Vice President and Chief of Staff - BioMap
  15. Unlocking Success to Biotech Global Expansion: A Stepwise Game Plan for International Launch
    Breakout Session
    • Emerging Opportunities in Global Markets
    26B
    Eduardo Schur
    Eduardo Schur, US Health Sciences & Wellness Commercial Strategy and R&D Lead - EY (Ernst & Young)
    Tolga Tanguler
    Tolga Tanguler, CCO - Alnylam Pharmaceuticals
    Russell Cox
    Russell Cox, President & CEO - Epirium Bio
    Robert LaCaze
    Robert LaCaze, CEO - Mnemo Therapeutics
    Ger Brophy
    Ger Brophy, Chair of the Scientific Advisory Board and retiring EVP Biopharma Production - Avantor
    Jérôme Revole
    Jérôme Revole, Managing Director Healthcare and Lifesciences - Business France North America
  16. Use of AI in mRNA: The New Revolution?
    Breakout Session
    • Next Generation Biotherapeutics
    23BC
    Andy French
    Andy French, Director, Data & AI - CGI
    Mathieu Blanchette
    Mathieu Blanchette, Director - McGill University
    Christian Barrow
    Christian Barrow, Executive Director - J.P. Morgan
    Petrina Kamya
    Petrina Kamya, Vice President and Global Head of AI Platforms, Insilico Medicine - President, Insilico Medicine Canada
    Andrew Giessel
    Andrew Giessel, Executive Director - Moderna
    Ashoka Madduri
    Ashoka Madduri, Head of Scientific Strategy and CI - mRNA CoE, Sanofi
  17. Varda Space Industries, Inc.
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    Mark Herbert
    Mark Herbert, Vice President, Business Development - Varda Space Industries, Inc.
4:30 PM – 4:45 PM
(PST)
  1. Concerto Biosciences
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    Cheri Ackerman
    Cheri Ackerman, CEO & Cofounder - Concerto Biosciences
  2. Japan - Global Innovation Hub
    Global Innovation Hub 5A
    Mikiro Suga
    Mikiro Suga, Senior Coordinator, Policy Planning Division for Pharmaceutical Industry Promotion and Medical Information Management, Health Policy Bureau - Ministry of Health, Labour and Welfare of Japan (MHLW)
    Hirokazu Shimoda
    Hirokazu Shimoda, Director, Bio-Industry Division, Commerce and Service Industry Policy Group - Ministry of Economy, Trade and Industry (METI)
    Nobutaka Maekawa
    Nobutaka Maekawa, Executive Vice President - Japan External Trade Organization (JETRO)
  3. Neuracle Genetics
    Company Presentation
    • Ophthalmology
    Company Presentation Theater 3
    Sunwoo Kim
    Sunwoo Kim, Head of Business Development - Neuracle Genetics
  4. QBiotics Group Limited
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Victoria Gordon
    Victoria Gordon, Executive Director Strategic Alliances & Investor Relations - QBiotics Group Limited
  5. TechInvention Lifecare Pvt Ltd
    Company Presentation
    • Infectious Disease and Vaccines
    Company Presentation Theater 2
    Syed Ahmed
    Syed Ahmed, Director & CEO - Techinvention Lifecare Private Limited
4:45 PM – 5:00 PM
(PST)
  1. Breye Therapeutics
    Company Presentation
    • Ophthalmology
    Company Presentation Theater 3
    Ulrik Mouritzen
    Ulrik Mouritzen, CEO - Breye Therapeutics
  2. Centivax, Inc.
    Company Presentation
    • Infectious Disease and Vaccines
    Company Presentation Theater 2
    Jacob Glanville
    Jacob Glanville, Founder & CEO - Centivax
  3. KAHR Bio
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Yaron Pereg
    Yaron Pereg, CEO - Kahr Medical Ltd.
  4. Talus Bio
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    Alex Federation
    Alex Federation, Co-Founder and CEO - Talus Bio
5:00 PM – 5:15 PM
(PST)
  1. Boryung Co., Ltd.
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Bong Seog Kim
    Bong Seog Kim, CTO - BORYUNG CO., LTD.
  2. Cytotheryx
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    John Swart
    John Swart, CEO - Cytotheryx
  3. Lynthera Corporation
    Company Presentation
    • Ophthalmology
    Company Presentation Theater 3
    Jeff Yang
    Jeff Yang, President & CEO - Lynthera Corporation
5:15 PM – 5:30 PM
(PST)
  1. ELEM Biotech
    Company Presentation
    • Tools/Drug Development Support Tech
    Company Presentation Theater 3
    Christopher Morton
    Christopher Morton, CEO - ELEM Biotech
  2. Kernal Bio
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    YUSUF ERKUL
    YUSUF ERKUL, CEO - Kernal Biologics
  3. Miracure Biotechnology
    Company Presentation
    • Infectious Disease and Vaccines
    Company Presentation Theater 2
    Xiaolin Li
    Xiaolin Li, FOUNDER/CEO - Miracure Biotechnology
  4. Pending AI
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    David Cardoso
    David Cardoso, Vice President, Business Development and Strategy - Pending AI
7:00 PM – 9:00 PM
(PST)
  1. Welcome Reception
    Reception Rady Shell at Jacobs Park
9:00 AM – 10:30 AM
(PST)
  1. Main Stage Opening Program
    Main Stage Program Ballroom 20
    Ted Love
    Ted Love, Chair - BIO Board of Directors
    Aaron Lazar
    Aaron Lazar, Actor, Singer, and Advocate
  2. The Convergence of Entrepreneurship and Innovation featuring Viola Davis
    Main Stage Program Ballroom 20
    Brooke Baldwin
    Brooke Baldwin, TV host, award-winning journalist and bestselling author
    Viola Davis
    Viola Davis, Award-Winning Actress, Producer, and New York Times Best-Selling Author
10:30 AM – 11:00 AM
(PST)
  1. ARC Medical Inc.
    Company Presentation
    • Medical Devices
    Company Presentation Theater 3
    Andrew Rae
    Andrew Rae, Consultant to ARC - Financing and Business Development - ARC Medical Inc.
  2. Company Presentations Tuesday
    Company Presentation Session Company Presentation Theaters
    johnson and johnson
  3. Elanco Animal Health
    Company Presentation
    • Animal Health Products
    Company Presentation Theater 2
    Steve Nanchen
    Steve Nanchen, Snr Director - Elanco Animal Health
  4. Entero Therapeutics formerly First Wave BioPharma
    Company Presentation
    • Gastrointestinal
    Company Presentation Theater 4
    James Sapirstein
    James Sapirstein, Chairman and CEO - First Wave BioPharma, Inc.
  5. Overcoming Development, Scale Up and Commercial Production Challenges for Novel Modalities
    BioProcess Theater BioProcess Theater
  6. Welcome Session: BioProcess Insider
    BioProcess Theater Session BioProcess Theater
    Dan Stanton
    Dan Stanton, Founder and Managing Editor - BioProcess Insider
  7. Zambon Biotech SA
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 1
    Cibele Sabido David
    Cibele Sabido David, Head of Business Development - Zambon Biotech
10:45 AM – 11:00 AM
(PST)
  1. Auxergen, Inc.
    Company Presentation
    • Food and Agriculture
    Company Presentation Theater 2
    Gregory Contreras
    Gregory Contreras, C.E.O. - Auxergen, Inc
  2. Pirouette Medical Inc.
    Company Presentation
    • Medical Devices
    Company Presentation Theater 3
    Conor Cullinane
    Conor Cullinane, President, CEO - Pirouette Medical Inc.
  3. Tonix Pharmaceuticals Holding Corp.
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 1
    Jessica Morris
    Jessica Morris, Chief Operating Officer - TONIX Pharmaceuticals
  4. YourChoice Therapeutics
    Company Presentation
    • Reproductive/Sexual Health
    Company Presentation Theater 4
    Akash Bakshi
    Akash Bakshi, CEO - YourChoice Therapeutics
11:00 AM – 11:30 AM
(PST)
  1. AI's Trial by Fire: Experimental Validation in Drug Discovery
    Breakout Session
    • AI and Digital Health
    24BC
    Nitya Sridhar
    Nitya Sridhar - Power
    Martin Akerman
    Martin Akerman, Co-founder and CTO - Envisagenics
    Alex Zhavoronkov
    Alex Zhavoronkov, Founder and CEO - InSilico Medicine
    Michael Bemben
    Michael Bemben, Director, Data Science and External Innovation - Johnson & Johnson
    Etai Jacob
    Etai Jacob, Senior Director, Head of Data Science and AI, Early Oncology - AstraZeneca
    Stacie Calad Thomson
    Stacie Calad Thomson, Vice Chairperson - Alliance for AI in Healthcare (AAIH)
  2. BioLattice Ophthalmics, Inc.
    Start-Up Stadium Session
    • Ophthalmology
    5B
    Amelia Zellander
    Amelia Zellander, CEO - BioLattice Ophthalmics, Inc.
  3. Black Canyon Bio
    Start-Up Stadium Session
    • Oncology
    5B
    Ken Carter
    Ken Carter
  4. Brick-by-Brick: Building a Biotech from Foundation Up with Venture Investor Company Formation
    Breakout Session
    • Business Development and Finance
    26B
    Allison DeAngelis
    Allison DeAngelis, Reporter - STAT News
    Ann Lee-Karlon
    Ann Lee-Karlon, Chief Executive Officer and President - EpiBiologics
    Amy Liu
    Amy Liu, Investor - Mubadala Capital
    Mitchell Mutz
    Mitchell Mutz, Entrepreneur Partner - Vivo Capital
    Sanjay Mistry
    Sanjay Mistry, Vice President - Johnson & Johnson Innovation
  5. Build Your Product Pipeline with Non-Dilutive Federal Resources
    Breakout Session
    • Business Development and Finance
    29AB
    Stephanie Fertig
    Stephanie Fertig, Director, NIH Small Business Program - National Institutes of Health (NIH)
    Elaine Haynes
    Elaine Haynes, President and CEO - KaloCyte, Inc.
    Julius Korley
    Julius Korley, Associate Vice President, Office of Economic Innovation and Partnerships - University of Delaware
    Meghan Wood
    Meghan Wood, Managing Director - New York Blood Center Ventures
    Anna Zornosa-Heymann
    Anna Zornosa-Heymann, Advisor, entrepreneur, investor Entrepreneur in Residence, National Institutes of Health (NIH) Advisor, Ignite Health Accelerator - Astia Fund and Hera Biotech
  6. Building a Bioscience Economy Through Supportive State Legislation: A Discussion with State Legislators from California, Massachusetts, and the Midwest
    Special Program
    • Regulatory Innovation
    29C
    Pete Pellerito
    Pete Pellerito, Senior Policy Adviser Federal/State Economic Development & Technology Transfer Lead - BIO
    Cottie Petrie-Norris
    Cottie Petrie-Norris, California Assemblywoman - 73rd Assembly District – Costa Mesa, Irvine and Tustin
    Chris Ward
    Chris Ward, California Assemblymember - 8th Assembly District - San Diego and El Cajon
    Jordan Rasmusson
    Jordan Rasmusson, Minnesota Senator
    John Lawn
    John Lawn, Massachusetts Representative - 10th District - Middlesex
  7. CELLeBRAIN, Ltd
    Start-Up Stadium Session
    • Oncology
    5B
    Haeyoung Suh-Kim
    Haeyoung Suh-Kim, CEO - CELLeBRAIN
  8. Daré Bioscience
    Company Presentation
    • Reproductive/Sexual Health
    Company Presentation Theater 4
  9. Super Session
    Decoding Biopharma's Public Image: Navigating 2024 Election Dynamics
    Super Session
    • Next Generation Biotherapeutics
    28ABCDE
    Genentech logo
    Fritz Bittenbender
    Fritz Bittenbender, Senior Vice President - Genentech
    Kathleen Rice
    Kathleen Rice
    Greg Walden
    Greg Walden, Former Chair - US House Energy and Commerce Committee
    Neil Newhouse
    Neil Newhouse, Partner and Co-Founder - Public Opinion Strategies
  10. FDA Townhall
    Special Program
    • Regulatory Innovation
    25ABC
    Steve Berman
    Steve Berman, Deputy Vice President, Science and Regulatory Affairs Strategy - Biotechnology Innovation Organization (BIO)
    Patrizia Cavazzoni
    Patrizia Cavazzoni, Director, Center for Drug Evaluation and Research - FDA
    Peter Marks
    Peter Marks, Director, Center for Biologics Evaluation and Research (CBER) - U.S. Food and Drug Administration
  11. FELIQS
    Start-Up Stadium Session
    • Ophthalmology
    5B
    Kenichiro Kuninobu
    Kenichiro Kuninobu, Co-founder and CEO - Feliqs
  12. Immunic Therapeutics
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 1
    Jessica Breu
    Jessica Breu, Vice President, Investor Relations and Communications - Immunic Therapeutics
  13. In and Out of This World: Partnering with Federal Labs
    Breakout Session
    • Business Development and Finance
    32AB
    Vladimir Popov
    Vladimir Popov, Chief Innovation Officer - Frederick National Laboratory for Cancer Research
    Edward Diehl
    Edward Diehl, Commercialization Officer - U.S. Army Medical Research and Development Command
    Tara Kirby
    Tara Kirby, Director of the Office of Technology Transfer - National Institutes of Health
    Michael Roberts
    Michael Roberts, Chief Scientific Officer - International Space Station National Laboratory
    Gillian Fenton
    Gillian Fenton, Vaccines Legal Operations - GSK
    Lisa Thomas Read
    Lisa Thomas Read, Vice President, Research and Development - Amivas (US), LLC
  14. Italian Trade Agency
    Global Innovation Hub 5A
    Marco Cito
    Marco Cito, Head of the Foreign Investments Attraction Department - Italian Trade Agency
  15. Jaan Biotherapeutics
    Start-Up Stadium Session
    • Cardiovascular
    5B
    Bhawanjit Brar
    Bhawanjit Brar, Chief Executive Officer - Jaan Biotherapeutics
  16. Mabswitch Inc
    Start-Up Stadium Session
    • Oncology
    5B
    Yemi Onakunle
    Yemi Onakunle, CEO - MabSwitch Inc
  17. Navigating the Future of Cell and Gene Therapy: Strategies for Innovation, Collaboration, and Market Success
    Breakout Session
    • Cell and Gene Therapy and Genome Editing
    30ABC
    cencora
    Lung-I Cheng
    Lung-I Cheng, Vice President, Cell and Gene Therapy - Cencora
    Irene Agodoa
    Irene Agodoa, Senior Vice President, Head of Medical Affairs - Orca Bio
    Adriana Herrera
    Adriana Herrera, Chief Executive Officer - Pierre Fabre Pharmaceuticals
    Brad Martin
    Brad Martin, Vice President, Head of Market Access and Trade - Neurotech Pharmaceuticals
    Robert Sexton
    Robert Sexton, former Senior Vice President, Strategy & Program Execution - Mustang Bio
  18. New Pain Therapeutics: Strategies for Innovation, Investment, and Collaboration
    Breakout Session
    • Next Generation Biotherapeutics
    23BC
    Hernan Bazan
    Hernan Bazan, CEO & Co-Founder - South Rampart Pharma, Inc.
    Emily Caporello
    Emily Caporello, Program Director, Division of Translational Research - NINDS, NIH
    Paige Cramer Lacatena
    Paige Cramer Lacatena, Director Business Development and Licensing, HQ Neurology - Merck
    Ana Moreno
    Ana Moreno, CEO and Founder - Navega Therapeutics
    Paul Mieyal
    Paul Mieyal, Managing Director - Outcome Capital, LLC
    Todd Bertoch
    Todd Bertoch, Chief Executive Officer at JBR Clinical Research - CenExel
  19. Orakl Oncology
    Start-Up Stadium Session
    • Oncology
    5B
    Fanny Jaulin
    Fanny Jaulin, Co-founder and CEO - Orakl Oncology
  20. SLAM BioTherapeutics, Inc.
    Start-Up Stadium Session
    • Oncology
    5B
    Steven Potts
    Steven Potts, CEO
  21. Spurring Biotech Innovation And Access Across the Globe: A High- Level Discussion
    Breakout Session
    • Emerging Opportunities in Global Markets
    30DE
    Marwan Abdulaziz Janahi
    Marwan Abdulaziz Janahi, Senior Vice President - Dubai Science Park
    Mansoor Al Mansoori
    Mansoor Al Mansoori, Chairman, Abu Dhabi Department of Health - UAE
    Lise Alter
    Lise Alter, General Manager - French Health Innovation Agency
  22. Start-Up Stadium Tuesday Morning
    Start-Up Stadium 5B
  23. Strengthening of the Clinical Trials Environment in Europe Under the Accelerating Clinical Trials (ACT EU) Initiative
    Breakout Session
    • Clinical Trials Innovations
    31C
    Laura Pioppo
    Laura Pioppo, ACT EU Programme manager - European Medicines Agency (EMA)
    Claire Skentelbery
    Claire Skentelbery, Director General - EuropaBio
    Carmen Laplaza-Santos
    Carmen Laplaza-Santos, Head of Unit Health Innovations and Ecosystems in Directorate General on Research and Innovation - European Commission
    Nathalie Seigneuret
    Nathalie Seigneuret, Senior Scientific Project Manager - Innovative Health Initiative (IHI)
    Thomas Bols
    Thomas Bols, Head of Government Affairs and Patient Engagement, EMEA & APAC - PTC Therapeutics
  24. Targeting the Brain: How Biotech is Uncovering the Biology of Brain Disease for Precision Neurotherapeutics
    Breakout Session
    • Brain Health
    26A
    Alaa Halawa
    Alaa Halawa, Executive Director and Head of Healthcare, US Ventures - Mubadala Capital
    Carol Suh
    Carol Suh, Co-founder & Chief Operating Officer - Neumora
    Joanne Taylor
    Joanne Taylor, Senior Vice President, Research - Gain Therapeutics
    Richard Shea
    Richard Shea, CEO - Basking Biosciences
    Craig Thompson
    Craig Thompson, CEO - Cerevance
  25. Vaxxas
    Company Presentation
    • Medical Devices
    Company Presentation Theater 3
    David Hoey
    David Hoey, Chief Executive Officer - Vaxxas
  26. What is Needed for Gene Therapy in the Future and How Close Are We?
    Session
    Larry Foreman
    Larry Foreman, CEO - CHO-Plus
  27. Zoetis
    Company Presentation
    • Animal Health Products
    Company Presentation Theater 2
    Stephane Shu Kin So
    Stephane Shu Kin So, Director, External Innovation - Zoetis
11:15 AM – 11:30 AM
(PST)
  1. Bionomics Ltd
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 1
    Spyros Papapetropoulos
    Spyros Papapetropoulos, President and CEO - Bionomics Ltd
  2. Boehringer Ingelheim Animal Health
    Company Presentation
    • Animal Health Products
    Company Presentation Theater 2
    Kate Christmas
    Kate Christmas, Director, Strategic Partnering AH - Boehringer Ingelheim
  3. Eydisbio Inc.
    Company Presentation
    • Orphan and Rare Disease
    Company Presentation Theater 4
    Scott Scarneo
    Scott Scarneo, Selective small molecule targeting of TAK1/TNF signaling in systemic sclerosis - EydisBio Inc.
  4. ICEX SPAIN TRADE & INVESTMENT
    Global Innovation Hub 5A
    Maria J. Fernandez
    Maria J. Fernandez, Trade Commissioner - Trade Commission of Spain in Chicago - ICEX Spain Trade & Investment
  5. Know Labs, Inc.
    Company Presentation
    • Medical Devices
    Company Presentation Theater 3
    Leo Trautwein
    Leo Trautwein, Chief Commercial Officer - Know Labs
11:30 AM – 1:00 PM
(PST)
  1. Boehringer Ingelheim
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 2
    Scott DeWire
    Scott DeWire, US Head, Business Development & Licensing - Boehringer Ingelheim
  2. Carcinotech
    Company Presentation
    • Oncology
    Company Presentation Theater 3
    Ishani Malhotra
    Ishani Malhotra, Founder & CEO - Carcinotech
  3. Lumos Pharma
    Company Presentation
    • Orphan and Rare Disease
    Company Presentation Theater 4
    Aaron Schuchart
    Aaron Schuchart, Chief Business Officer - Lumos Pharma
  4. Neuren Pharmaceuticals
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 1
    Jon Pilcher
    Jon Pilcher, CEO - Neuren Pharmaceuticals
  5. Polish Investment and Trade Agency
    Global Innovation Hub 5A
    Zuzanna Kobrzynski
    Zuzanna Kobrzynski, Polish Investment and Trade Agency - Polish Investment and Trade Agency
  6. Premier & General Attendee Lunch
    Session Sails Pavilion
11:40 AM – 12:00 PM
(PST)
  1. What unseen trouble lies within your processes? Increasing confidence in preventing microbial contamination with efficient decontamination in Biopharmaceutical and ATMP manufacturing
    BioProcess Theater Session
    Madison Hoal
    Madison Hoal, Senior Global Technical Consultant - Ecolab Life Sciences
11:45 AM – 12:00 PM
(PST)